Clair Labs
Contact-free Patient Monitoring
Company Overview
Snapshot
Founded in July 2017 by Adi Berenson and Ran Margolin, Clair Labs operated with 1–10 employees. The company raised a total of $9 million across three funding rounds from four investors. In June 2021, Clair Labs secured funding from investors including.
Business overview
Clair Labs develops remote patient monitoring technology for medical-grade, contact-free acquisition of physiological markers. Its core product is a cloud-based service that offers physicians and caregivers a real-time and secure method for continuously monitoring patients remotely, whether in care facilities or at home. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Remote Monitoring, serving the United States, Israel, and global markets.
Strategic signal
In June 2023, Clair Labs ceased operations, indicating a significant shift in its business trajectory. This event signals to investors and innovation teams that the company is no longer an active player in the remote patient monitoring market, despite having raised substantial seed funding. The closure suggests potential challenges in market adoption, technology commercialization, or competitive pressures within the digital health space.
Log in to access full profile ›Company Intelligence Q&A
- What is Clair Labs' primary focus?
- Clair Labs specializes in developing contact-free patient monitoring technology for medical-grade acquisition of physiological markers and a cloud-based service for remote patient monitoring.
- When was Clair Labs founded and by whom?
- Clair Labs was founded in July 2017 by Adi Berenson and Ran Margolin.
- What is the current operational status of Clair Labs?
- Clair Labs ceased to operate in June 2023.
- Which markets does Clair Labs target?
- Clair Labs targets the United States, Israel, and global markets with its remote patient monitoring solutions.